Is Neurocrine Biosciences, Inc. overvalued?

Neurocrine Biosciences, Inc. (NBIX) looks undervalued — trading about 44% below its fair value.

Undervalued

Price

$167.40

Fair value

$240.96

Current P/E

24.2

Normal P/E

34.8

Market cap

$16.94B

Dividend yield

0.0%

Return on equity

19.7%

Sector

Healthcare

Fair value compares NBIX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks